Dr. Aaron Carrithers brings a founder’s mindset and extensive firsthand experience, guiding biotech teams through complicated ...

New senior teaching faculty will also lead University’s Teaching/Learning and Research programmes in the Middle East ...

A recent study outlines key background ... royalty rates in the modern environment, click here for the full report, Royalty Rate Derivation for Pharmaceuticals &amp, Biotechnology, sponsored ...

Transforming Preclinical Screening with Speed, Precision, and Scalability. Explore How This Model Organism is Shaping the Next Era of Pharmaceutical Innovation. Executive Summary & Key Findings Market ...

Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...

Activities planned worldwide and year-round aim to commemorate the advent of quantum mechanics 100 years ago and highlight ...

Two of the traits that set modern humans apart from non-human primates are taller stature and a higher basal metabolic rate. Researchers have identified a genetic variant that contributed to the ...

The foundations of psychedelic capitalism were largely created by public innovation at the public’s expense and are now in ...

Modern biotechnology began in 1973 when scientists used recombination to genetically engineer an antibiotic-resistant strain of Escherichia coli bacteria. This began a revolution in molecule ...

PDS Biotechnology Corporation (NASDAQ:PDSB) unveiled compelling new data on its Versamune HPV (PDS0101) immunotherapy at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

This fund holds a portfolio of 75-125 biotechnology stocks, balanced between established large-cap names and smaller companies with more growth potential but also more risk. The managers aim to ...